479 related articles for article (PubMed ID: 24635395)
1. Detecting doping use: more than an analytical problem.
Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
[TBL] [Abstract][Full Text] [Related]
2. Detection of autologous blood transfusions in athletes: a historical perspective.
Mørkeberg J
Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
[TBL] [Abstract][Full Text] [Related]
3. Detection methods for autologous blood doping.
Segura J; Monfort N; Ventura R
Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
[TBL] [Abstract][Full Text] [Related]
4. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
Schumacher YO; Saugy M; Pottgiesser T; Robinson N
Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
[TBL] [Abstract][Full Text] [Related]
5. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
[TBL] [Abstract][Full Text] [Related]
6. Current implementation and future of the Athlete Biological Passport.
Sottas PE; Vernec A
Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480
[TBL] [Abstract][Full Text] [Related]
7. OMICS-strategies and methods in the fight against doping.
Reichel C
Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
[TBL] [Abstract][Full Text] [Related]
8. Blood doping: the flip side of transfusion and transfusion alternatives.
Cacic DL; Hervig T; Seghatchian J
Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798
[TBL] [Abstract][Full Text] [Related]
9. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
Vernec AR
Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
[TBL] [Abstract][Full Text] [Related]
10. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
Robinson N; Sottas PE; Schumacher YO
Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
[TBL] [Abstract][Full Text] [Related]
11. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers.
Mørkeberg J; Sharpe K; Belhage B; Damsgaard R; Schmidt W; Prommer N; Gore CJ; Ashenden MJ
Scand J Med Sci Sports; 2011 Apr; 21(2):235-43. PubMed ID: 19903320
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the biological passport: the experience of the International Cycling Union.
Zorzoli M; Rossi F
Drug Test Anal; 2010; 2(11-12):542-7. PubMed ID: 21204287
[TBL] [Abstract][Full Text] [Related]
13. A third generation approach to detect erythropoietin abuse in athletes.
Sharpe K; Ashenden MJ; Schumacher YO
Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
[TBL] [Abstract][Full Text] [Related]
14. Case studies on ESA-doping as revealed by the Biological Passport.
Zorzoli M; Rossi F
Drug Test Anal; 2012 Nov; 4(11):854-8. PubMed ID: 22514122
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in the detection of human erythropoietin and human growth hormone doping].
Guo L; Zhang Z; Tang J; Xie J
Se Pu; 2008 Jul; 26(4):437-43. PubMed ID: 18959238
[TBL] [Abstract][Full Text] [Related]
16. Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
Ashenden M; Gough CE; Garnham A; Gore CJ; Sharpe K
Eur J Appl Physiol; 2011 Sep; 111(9):2307-14. PubMed ID: 21336951
[TBL] [Abstract][Full Text] [Related]
17. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
[TBL] [Abstract][Full Text] [Related]
18. Detection of peptidic erythropoiesis-stimulating agents in sport.
Reichel C
Br J Sports Med; 2014 May; 48(10):842-7. PubMed ID: 24677025
[TBL] [Abstract][Full Text] [Related]
19. Abuse of medicines for performance enhancement in sport: why is this a problem for the pharmaceutical industry?
Elliott S; Leishman B
Bioanalysis; 2012 Jul; 4(13):1681-90. PubMed ID: 22831483
[TBL] [Abstract][Full Text] [Related]
20. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
